‘Follow the science’ isn’t a covid-19 strategy | Health/Science

Anyone observing President Donald Trump’s handling of the coronavirus pandemic in the U.S. would have good reason to wonder if his administration ever had much of a strategy for handling it. Recently the press accused one of his medical advisers, Scott Atlas, of promoting a “herd immunity strategy” amounting to letting COVID-19 run rampant. Atlas denies this, but a more important issue is what our strategy is, or should be, and what Joe Biden’s strategy would be if he’s elected.

As it turns out, neither man has put forward much of a plan.

Biden’s promise to “follow the science” does not amount to a strategy. It’s just a slogan. A strategy to deal with the pandemic needs to set priorities and incorporate values that science isn’t equipped to provide.

Science can give insights into the nature of the pandemic, but there is no scientific formula pointing to a solution. Any

Read More

GLOBAL MARKETS-Asian stocks follow Wall Street lower, nervous wait for U.S. jobs data

* Tech leads modest losses across Asia

* MSCI AxJ down 1.5%, shallower than 5% Nasdaq plunge

* Limited spillover into currency and bond markets; payrolls eyed

* Asian stock markets: https://tmsnrt.rs/2zpUAr4

By Tom Westbrook

SINGAPORE, Sept 4 (Reuters) – Asia’s stock markets had their worst session in two weeks on Friday following a tech-led plunge on Wall Street, though gains in safer assets like bonds and dollars were muted as investors awaited U.S. job data to see if it triggers a bigger selloff.

MSCI’s broadest index of Asia-Pacific shares outside Japan fell 1.5% and looked set to snap a six-week winning streak with a 2.3% weekly loss, its biggest since April.

The Nikkei declined 1%. Australia’s ASX 200 led losses with a 3% fall as global investors sold growth-exposed miners like BHP and traders trimmed positions ahead of the weekend in case Wall Street takes another dive.

Elsewhere drops

Read More